MPTP
Overview[edit | edit source]
MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is a chemical compound that is of significant interest in the field of neuroscience and pharmacology. It is a neurotoxin that selectively destroys dopaminergic neurons in the substantia nigra, leading to symptoms similar to those of Parkinson's disease.
History[edit | edit source]
MPTP was first synthesized in the 1970s as a byproduct during the illicit production of the synthetic opioid MPPP. It gained notoriety in the early 1980s when it was discovered that individuals who had consumed MPTP-contaminated drugs developed severe and irreversible parkinsonism. This led to its use as a tool for creating animal models of Parkinson's disease for research purposes.
Mechanism of Action[edit | edit source]
MPTP itself is not directly toxic. It crosses the blood-brain barrier and is metabolized by the enzyme monoamine oxidase B (MAO-B) in glial cells to form MPP+ (1-methyl-4-phenylpyridinium), which is the active toxic agent. MPP+ is taken up by dopaminergic neurons via the dopamine transporter and accumulates in the mitochondria, where it inhibits complex I of the electron transport chain. This inhibition leads to mitochondrial dysfunction, oxidative stress, and ultimately, neuronal death.
Clinical Significance[edit | edit source]
The discovery of MPTP's effects on the brain has provided valuable insights into the pathophysiology of Parkinson's disease. It has been used extensively in research to develop and test new therapeutic strategies for the treatment of Parkinson's disease. MPTP-induced parkinsonism in animal models has helped in understanding the role of dopamine in motor control and the potential for neuroprotective agents to prevent or slow the progression of neurodegenerative diseases.
Safety and Handling[edit | edit source]
Due to its potent neurotoxic effects, MPTP is handled with extreme caution in research settings. It is classified as a hazardous substance, and appropriate safety protocols must be followed to prevent accidental exposure.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
